Clinical Procedure Exposures and Rare or Poorly Understood Cancers: A Case-control Study Using Electronic Health Records.
- 1MU Institute for Data Science and Informatics (MUIDSI), University of Missouri Columbia MO USA.
- 2Department of Biomedical Informatics, Biostatistics and Medical Epidemiology (BBME), University of Missouri School of Medicine Columbia MO USA.
- 3Center for Medical Epidemiology and Population Health (CMEPH), University of Missouri School of Medicine Columbia MO USA.
Abstract
Rare and poorly understood cancers (RPUC) represent a heterogeneous group of diseases for which risk factors remain unexplored. We evaluated associations between four selected clinical exposures and a composite outcome of 12 RPUC. We conducted four matched case-control analyses using electronic health record data from the University of Missouri Health Care system. Composite outcome cases were matched 1 : 3 to controls on sex, race, Hispanic ethnicity, marital status, age group, and diagnosis year group. Conditional logistic regression estimated associations for radiation procedures, hormone therapy, orthopedic implants, and breast implants (matched OR [mOR]). Models adjusted for body mass index, smoking, healthcare utilization, Charlson Comorbidity Index, and additional breast implant analysis covariates. The radiation analysis included 679 cases and 2,037 controls; hormone therapy, 1,019 cases and 3,057 controls; orthopedic implants, 726 cases and 2,178 controls; and breast implants, 1,344 cases and 4,032 controls. Radiation exposure was not significantly associated with case status after adjustment (mOR, 0.94; 95% CI, 0.75-1.18). Hormone therapy was positively associated with case status (mOR, 1.32; 95% CI, 1.05-1.66), as were orthopedic implants (mOR, 2.68; 95% CI, 1.38-5.21). Breast implant exposure was not significantly associated with case status (mOR, 0.67; 95% CI, 0.18-2.50). In conclusion, the composite outcome was positively associated with hormone therapy and orthopedic implant. Given the heterogeneity of the cancers included, simplified exposure definitions, potential residual confounding, and incomplete electronic health record ascertainment, these findings should be interpreted as exploratory (hypothesis-generating) and warrant cancer-specific evaluation.
Related
- Regenerative Endodontic Procedure in Mandibular First Molar: A Clinical Case Report
- GClnc1 as an emerging oncogenic regulator with mechanistic insights and clinical implications in human cancers
- The Least Understood Placental Galectins: Galectin-14 and Galectin-16 in Human Pregnancy and Placental Biology
- Clinical efficacy and prognostic factors of regenerative endodontic procedure for immature permanent teeth with periapical periodontitis.
- Intradiscal Nucleus Pulposus Allograft Versus Sham Procedure in Patients with Lumbar Discogenic Pain: A Randomized Clinical Trial
BibTeX
@article{jaddoo2026clinical,
title = {{Clinical Procedure Exposures and Rare or Poorly Understood Cancers: A Case-control Study Using Electronic Health Records.}},
author = {Julie P Jaddoo and Chester Lee Schmaltz and Sueny Paloma Lima Dos Santos and Lincoln R Sheets and Jeannette Jackson-Thompson and Eduardo J Simoes},
journal = {Journal of cancer prevention},
year = {2026},
month = oct,
doi = {10.15430/jcp.26.016},
url = {https://europepmc.org/article/MED/42996512},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Clinical Procedure Exposures and Rare or Poorly Understood Cancers: A Case-control Study Using Electronic Health Records.
AU - Julie P Jaddoo
AU - Chester Lee Schmaltz
AU - Sueny Paloma Lima Dos Santos
AU - Lincoln R Sheets
AU - Jeannette Jackson-Thompson
AU - Eduardo J Simoes
PY - 2026
DA - 2026/10/01
JO - Journal of cancer prevention
DO - 10.15430/jcp.26.016
UR - https://europepmc.org/article/MED/42996512
AB - Rare and poorly understood cancers (RPUC) represent a heterogeneous group of diseases for which risk factors remain unexplored. We evaluated associations between four selected clinical exposures and a composite outcome of 12 RPUC. We conducted four matched case-control analyses using electronic health record data from the University of Missouri Health Care system. Composite outcome cases were matched 1 : 3 to controls on sex, race, Hispanic ethnicity, marital status, age group, and diagnosis year group. Conditional logistic regression estimated associations for radiation procedures, hormone therapy, orthopedic implants, and breast implants (matched OR [mOR]). Models adjusted for body mass index, smoking, healthcare utilization, Charlson Comorbidity Index, and additional breast implant analysis covariates. The radiation analysis included 679 cases and 2,037 controls; hormone therapy, 1,019 cases and 3,057 controls; orthopedic implants, 726 cases and 2,178 controls; and breast implants, 1,344 cases and 4,032 controls. Radiation exposure was not significantly associated with case status after adjustment (mOR, 0.94; 95% CI, 0.75-1.18). Hormone therapy was positively associated with case status (mOR, 1.32; 95% CI, 1.05-1.66), as were orthopedic implants (mOR, 2.68; 95% CI, 1.38-5.21). Breast implant exposure was not significantly associated with case status (mOR, 0.67; 95% CI, 0.18-2.50). In conclusion, the composite outcome was positively associated with hormone therapy and orthopedic implant. Given the heterogeneity of the cancers included, simplified exposure definitions, potential residual confounding, and incomplete electronic health record ascertainment, these findings should be interpreted as exploratory (hypothesis-generating) and warrant cancer-specific evaluation.
SN - 2288-3649
SN - 2288-3657
ER -